Characteristics
|
OS
|
DFS
|
---|
Univariate
|
Multivariate
|
Univariate
|
Multivariate
|
---|
HR (95CI)
|
P-value
|
HR (95CI)
|
P-value
|
HR (95CI)
|
P-value
|
HR (95CI)
|
P-value
|
---|
Age (years)
|
1.00 (0.99–1.01)
|
0.818
| | |
1.00 (0.99–1.01)
|
0.852
| | |
Sex (Male vs Female)
|
0.95 (0.77–1.16)
|
0.611
| | |
0.99 (0.84–1.18)
|
0.950
| | |
HBV infection (Yes vs No)
|
1.01 (0.80–1.28)
|
0.908
| | |
1.13 (0.93–1.38)
|
0.208
| | |
Cirrhosis (Yes vs No)
|
0.95 (0.81–1.11)
|
0.498
| | |
1.08 (0.95–1.24)
|
0.237
| | |
TBil (μmol/L)
|
1.02 (1.01–1.03)
|
0.003
|
1.01 (1.00–1.02)
|
0.087
|
1.01 (1.00–1.02)
|
0.010
|
1.01 (1.00–1.02)
|
0.186
|
Child-pugh (B vs A)
|
2.04 (1.54–2.70)
|
< 0.001
|
1.27 (0.93–1.72)
|
0.131
|
1.72 (1.34–2.20)
|
< 0.001
|
1.13 (0.86–1.49)
|
0.371
|
AFP (> 400 vs 400 ng/mL)
|
1.66 (1.43–1.94)
|
< 0.001
|
1.43 (1.22–1.67)
|
< 0.001
|
1.35 (1.19–1.54)
|
< 0.001
|
1.22 (1.07–1.40)
|
0.004
|
γ-GT (> 54 vs ≤54 U/L)
|
1.76 (1.51–2.05)
|
< 0.001
|
1.38 (1.17–1.62)
|
< 0.001
|
1.69 (1.49–1.92)
|
< 0.001
|
1.42 (1.24–1.63)
|
< 0.001
|
Transfusion (Yes vs No)
|
2.01 (1.54–2.61)
|
< 0.001
|
0.89 (0.66–1.22)
|
0.479
|
1.97 (1.57–2.48)
|
< 0.001
|
1.12 (0.86–1.46)
|
0.391
|
Tumor number (Multiple vs Single)
|
1.83 (1.54–2.17)
|
< 0.001
|
1.50 (1.23–1.82)
|
< 0.001
|
1.82 (1.58–2.10)
|
< 0.001
|
1.53 (1.29–1.80)
|
< 0.001
|
Tumor diameter (cm)
|
1.11 (1.09–1.13)
|
< 0.001
|
1.07 (1.05–1.09)
|
< 0.001
|
1.08 (1.06–1.09)
|
< 0.001
|
1.04 (1.02–1.06)
|
< 0.001
|
ES grading (III/IV vs I/II)
|
1.80 (1.34–2.42)
|
< 0.001
|
1.28 (0.95–1.74)
|
0.108
|
1.42 (1.13–1.78)
|
0.003
|
1.08 (0.85–1.37)
|
0.528
|
Capsule (Absent vs Present)
|
1.42 (1.20–1.70)
|
< 0.001
|
1.35 (1.12–1.62)
|
0.001
|
1.26 (1.09–1.47)
|
0.002
|
1.16 (0.99–1.35)
|
0.064
|
Satellite (Yes vs No)
|
1.51 (1.30–1.75)
|
< 0.001
|
0.98 (0.81–1.18)
|
0.812
|
1.46 (1.29–1.66)
|
< 0.001
|
1.05 (0.90–1.22)
|
0.527
|
MVI (Absent vs Present)
|
1.92 (1.65–2.23)
|
< 0.001
|
1.51 (1.27–1.79)
|
< 0.001
|
1.68 (1.48–1.90)
|
< 0.001
|
1.40 (1.22–1.62)
|
< 0.001
|
PA-TACE (Yes vs No)
|
0.89 (0.75–1.05)
|
0.165
| | |
0.93 (0.81–1.06)
|
0.280
| | |
- Note: OS overall survival; DFS disease-free survival; HR hazard ratio; CI confidence interval; HBV hepatitis B virus, TBil total bilirubin; AFP alpha-fetoprotein; γ-GT gamma-glutamyl transferase; ES Edmondson-Steiner; MVI microvascular invasion; PA-TACE postoperative adjuvant transarterial chemoembolization